---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-26-000091"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-06-12T20:56:39+00:00"
generated_at: "2026-06-12T20:58:29.536337+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies enters $1M revolving loan at 12% with Bowery Group; board overhaul with 3 new directors

## Summary
- Entered $1,000,000 revolving loan agreement with Bowery Group LLC at 12% interest, 16% default rate, 1-year maturity.
- Three directors (Francisco Silva, Nickolay Kukekov, Patrick F. Williams) resigned effective June 11, 2026.
- Lender designees Mika Grasso, Katharyn Field, Jatinder Dhaliwal appointed to board as Class II, I, III directors respectively.
- Loan proceeds for general corporate purposes; lender controls board composition via appointment rights.
- Mr. Grasso chairs Audit Committee; Ms. Field chairs Nominating; Mr. Dhaliwal on all three committees.

## SEC filing metadata
- accession: 0001021771-26-000091
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-06-12T20:56:39+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/brtx-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-26-000091
- JSON: https://secwatch.observer/filing/0001021771-26-000091.json
- Plain text: https://secwatch.observer/filing/0001021771-26-000091.txt

## Key facts
- Executive change
  Jatinder Dhaliwal was appointed as Director at BioRestorative Therapies, Inc..
  - Action: appointed
  - Role: Director
  source text: the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Executive change
  Nickolay Kukekov resigned as Director at BioRestorative Therapies, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Executive change
  Francisco Silva resigned as Director at BioRestorative Therapies, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Executive change
  Patrick F. Williams resigned as Director at BioRestorative Therapies, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Executive change
  Mika Grasso was appointed as Director at BioRestorative Therapies, Inc..
  - Action: appointed
  - Role: Director
  source text: the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Executive change
  Katharyn Field was appointed as Director at BioRestorative Therapies, Inc..
  - Action: appointed
  - Role: Director
  source text: the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm
- Material Agreements
  BioRestorative Therapies, Inc. entered into Revolving Loan Agreement with Bowery Group LLC valued at Loans up to $1,000,000 aggregate principal; interest rate 12% per annum; default rate 16% per annum; (effective 2026-06-10).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Bowery Group LLC
  - Value: Loans up to $1,000,000 aggregate principal; interest rate 12% per annum; default rate 16% per annum;
  - Effective: 2026-06-10
  source text: On June 10, 2026, BioRestorative Therapies, Inc. (the “Company”) entered into a Revolving Loan Agreement (the “Revolving Loan Agreement”) with Bowery Group LLC (the “Lender”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.